CanSino Biologics Inc.

CDC panel to review booster for children aged 5 to 11 as U.S. cases climb 57% from two weeks ago – News Opener

A team of advisers to the Centers for Disease Control and Prevention will meet Thursday to review a third dose…

Read More »